Our Science
Previse has licensed cutting-edge biomarker technology focused on the prediction and detection of esophageal cancer from Johns Hopkins University. We are actively working to unlock the power of DNA methylation on disease development and severity to get patients and healthcare providers the answers they need…sooner.
Explore this section for more information.
Biomarkers in Early Detection of Cancer
What are molecular biomarkers? What is DNA methylation and why is it important?
EsopredictTM Publications
We are committed to developing a solid body of evidence that consistently validates our solutions across every stage of development.
Pipeline Publications
By developing a pipeline of epigenetic diagnostic and prognostic tests through collaboration with world-renowned researchers, we believe we can change the paradigm of cancer prevention and earlier diagnosis of the world’s most lethal cancers.